Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-143 vs Simvastatin in Hypercholesterolemia
NCT00812955Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibric acid + rosuvastatin in hypercholesterolemia, hypertriglyceridemia, dyslipidemia, sponsored by AstraZeneca. Started Nov 2008; status: completed.
02
Drugs
fenofibric acid + rosuvastatin
03
Conditions
hypercholesterolemiahypertriglyceridemiadyslipidemia
Beyond the preview
Go deeper on NCT00812955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812955.